Rocky Mountain Cancer Centers (US Oncology/McKesson) — Boulder, Colorado

Rocky Mountain Cancer Centers (US Oncology/McKesson) is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers (US Oncology/McKesson) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Sponsors: Swedish Orphan Biovitrum.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers (US Oncology/McKesson)?

Rocky Mountain Cancer Centers (US Oncology/McKesson) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers (US Oncology/McKesson) conducted?

Rocky Mountain Cancer Centers (US Oncology/McKesson) has 1 clinical trials on record, with 1 currently active. Their work covers Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Is Rocky Mountain Cancer Centers (US Oncology/McKesson) accredited by Crixeo Health?

Rocky Mountain Cancer Centers (US Oncology/McKesson) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers (US Oncology/McKesson)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.